Journal of Biological Chemistry · 2008 · 77 citations · 32 references
Life SciencesBiochemistryMolecular BiologyLipid BiochemistryProtein BiochemistryProtein-protein InteractionsLipid MetabolismLipoprotein MetabolismPlasma ProteinsProtein-lipid InteractionsApolipoprotein FunctionApolipoprotein Regulation
Lipoproteins consist of lipids solubilized by apolipoproteins. The lipid-binding structural motifs of apolipoproteins include amphipathic α-helixes and β-sheets. Plasma apolipoprotein (apo) M lacks an external amphipathic motif but, nevertheless, is exclusively associated with lipoproteins (mainly high density lipoprotein). Uniquely, however, apoM is secreted to plasma without cleavage of its hydrophobic NH2-terminal signal peptide. To test whether the signal peptide serves as a lipoprotein anchor for apoM in plasma, we generated mice expressing a mutated apoMQ22A cDNA in the liver (apoMQ22A-Tg mice (transgenic mice)) and compared them with mice expressing wild-type human apoM (apoM-Tg mice). The substitution of the amino acid glutamine 22 with alanine in apoMQ22A results in secretion of human apoM without a signal peptide. The human apoM mRNA level in liver and the amount of human apoM protein secretion from hepatocytes were similar in apoM-Tg and apoMQ22A-Tg mice. Nevertheless, human apoM was not detectable in plasma of apoMQ22A-Tg mice, whereas it was easily measured in the apoM-Tg mice. To examine the plasma metabolism, recombinant apoM lacking the signal peptide was produced in Escherichia coli and injected into wild-type mice. The apoM without signal peptide did not associate with lipoproteins and was rapidly cleared in the kidney. Accordingly, ligation of the kidney arteries in apoMQ22A-Tg mice resulted in rapid accumulation of human apoM in plasma. The data suggest that hydrophobic signal peptide sequences, if preserved upon secretion, can anchor plasma proteins in lipoproteins. In the case of apoM, this mechanism prevents rapid loss by filtration in the kidney. Lipoproteins consist of lipids solubilized by apolipoproteins. The lipid-binding structural motifs of apolipoproteins include amphipathic α-helixes and β-sheets. Plasma apolipoprotein (apo) M lacks an external amphipathic motif but, nevertheless, is exclusively associated with lipoproteins (mainly high density lipoprotein). Uniquely, however, apoM is secreted to plasma without cleavage of its hydrophobic NH2-terminal signal peptide. To test whether the signal peptide serves as a lipoprotein anchor for apoM in plasma, we generated mice expressing a mutated apoMQ22A cDNA in the liver (apoMQ22A-Tg mice (transgenic mice)) and compared them with mice expressing wild-type human apoM (apoM-Tg mice). The substitution of the amino acid glutamine 22 with alanine in apoMQ22A results in secretion of human apoM without a signal peptide. The human apoM mRNA level in liver and the amount of human apoM protein secretion from hepatocytes were similar in apoM-Tg and apoMQ22A-Tg mice. Nevertheless, human apoM was not detectable in plasma of apoMQ22A-Tg mice, whereas it was easily measured in the apoM-Tg mice. To examine the plasma metabolism, recombinant apoM lacking the signal peptide was produced in Escherichia coli and injected into wild-type mice. The apoM without signal peptide did not associate with lipoproteins and was rapidly cleared in the kidney. Accordingly, ligation of the kidney arteries in apoMQ22A-Tg mice resulted in rapid accumulation of human apoM in plasma. The data suggest that hydrophobic signal peptide sequences, if preserved upon secretion, can anchor plasma proteins in lipoproteins. In the case of apoM, this mechanism prevents rapid loss by filtration in the kidney. Lipoproteins consist of lipids (mainly cholesterol, phospholipids, and triglycerides) solubilized by apolipoproteins. The apolipoproteins play essential roles in controlling plasma and tissue lipid homeostasis by interacting with cellular lipoprotein receptors (the low density lipoprotein receptor, the scavenger receptor class B type-I, the ATP-binding cassette transporter AI, etc.) and enzymes (e.g. lecithin-cholesterol acyltransferase, hepatic lipase, and lipoprotein lipase) and lipid transfer protein (cholesteryl ester transfer protein and phospholipid transfer protein). However, several apolipoproteins have roles beyond lipid metabolism. Indeed, a recent shotgun proteomic approach revealed that HDL 3The abbreviations used are: HDL, high density lipoprotein; HRP, haptoglobin-related protein; PON-1, paraoxonase 1; TC, tyramine cellobiose; Tg, transgenic; apo, apolipoprotein; ELISA, enzyme-linked immunosorbent assay. 3The abbreviations used are: HDL, high density lipoprotein; HRP, haptoglobin-related protein; PON-1, paraoxonase 1; TC, tyramine cellobiose; Tg, transgenic; apo, apolipoprotein; ELISA, enzyme-linked immunosorbent assay. on average contains >40 proteins, of which many affect complement activation or protease inhibition (1Vaisar T. Pennathur S. Green P.S. Gharib S.A. Hoofnagle A.N. Cheung M.C. Byun J. Vuletic S. Kassim S. Singh P. Chea H. Knopp R.H. Brunzell J. Geary R. Chait A. Zhao X.Q. Elkon K. Marcovina S. Ridker P. Oram J.F. Heinecke J.W. J. Clin. Investig. 2007; 117: 746-756Crossref PubMed Scopus (786) Google Scholar). Also, several well known HDL apolipoproteins have roles in inflammation and host defense against microbial infections (1Vaisar T. Pennathur S. Green P.S. Gharib S.A. Hoofnagle A.N. Cheung M.C. Byun J. Vuletic S. Kassim S. Singh P. Chea H. Knopp R.H. Brunzell J. Geary R. Chait A. Zhao X.Q. Elkon K. Marcovina S. Ridker P. Oram J.F. Heinecke J.W. J. Clin. Investig. 2007; 117: 746-756Crossref PubMed Scopus (786) Google Scholar). For instance, apoL is involved in fighting Trypanosoma infections (2Vanhamme L. Paturiaux-Hanocq F. Poelvoorde P. Nolan D.P. Lins L. Van Den A.J. Pays A. Tebabi P. Van X.H. Jacquet A. Moguilevsky N. Dieu M. Kane J.P. De B.P. Brasseur R. Pays E. Nature. 2003; 422: 83-87Crossref PubMed Scopus (362) Google Scholar), and apoJ (clusterin) has even been proposed to play a significant role in tumorigenesis (3Trougakos I.P. Gonos E.S. Int. J. Biochem. Cell Biol. 2002; 34: 1430-1448Crossref PubMed Scopus (318) Google Scholar). For apolipoproteins without any (known) effect on plasma lipid metabolism, it is conceivable that the host HDL particle mainly serves as a carrier that prevents rapid removal of its associated apolipoproteins (e.g. by filtration in the kidney) or perhaps aids in their assembly at sites of inflammation. The structural motifs conferring the lipid-binding capacity of apolipoproteins has been most intensively studied for apoB in low density lipoprotein (4Segrest J.P. Jones M.K. De L.H. Dashti N. J. Lipid Res. 2001; 42: 1346-1367Abstract Full Text Full Text PDF PubMed Google Scholar) and apoA-I in HDL (5Davidson W.S. Silva R.A. Curr. Opin. Lipidol. 2005; 16: 295-300Crossref PubMed Scopus (75) Google Scholar, 6Davidson W.S. Hazlett T. Mantulin W.W. Jonas A. Proc. Natl. Acad. Sci. U. S. A. 1996; 93: 13605-13610Crossref PubMed Scopus (133) Google Scholar). Both amphipathic α-helixes (7Segrest J.P. Jackson R.L. Morrisett J.D. Gotto Jr., A.M. FEBS Lett. 1974; 38: 247-258Crossref PubMed Scopus (486) Google Scholar) and β-sheets (4Segrest J.P. Jones M.K. De L.H. Dashti N. J. Lipid Res. 2001; 42: 1346-1367Abstract Full Text Full Text PDF PubMed Google Scholar) bind to the lipids. In the case of apoA-I and several other HDL apolipoproteins (e.g. apoE and the apoCs), the non-covalent binding of the amphipathic α-helixes are rather weak, allowing exchange of the apolipoproteins between the triglyceride-rich very low density lipoprotein and chylomicron particles and HDL (8Atkinson D. Small D.M. Annu. Rev. Biophys. Biophys. Chem. 1986; 15: 403-456Crossref PubMed Scopus (136) Google Scholar). Indeed, some apolipoproteins are so loosely bound to HDL (e.g. apoJ (9Christoffersen C. Nielsen L.B. Axler O. Andersson A. Johnsen A.H. Dahlback B. J. Lipid Res. 2006; 47: 1833-1843Abstract Full Text Full Text PDF PubMed Scopus (151) Google Scholar), apoA-IV (10Christoffersen C. Jauhiainen M. Moser M. Porse B. Ehnholm C. Boesl M. Dahlback B. Nielsen L.B. J. Biol. Chem. 2007; 283: 1839-1847Abstract Full Text Full Text PDF PubMed Scopus (151) Google Scholar), and lecithin-cholesterol acyltransferase (11Cheung M.C. Wolf A.C. Lum K.D. Tollefson J.H. Albers J.J. J. Lipid Res. 1986; 27: 1135-1144Abstract Full Text PDF PubMed Google Scholar) that they are often stripped from the lipoprotein particles during preparative ultracentrifugation. ApoM (188 amino acids) was discovered in 1999 by Xu and Dahlback (12Xu N. Dahlback B. J. Biol. Chem. 1999; 274: 31286-31290Abstract Full Text Full Text PDF PubMed Scopus (270) Google Scholar). In plasma, apoM is exclusively found in association with lipoproteins (mainly HDL). Recent studies of mice with genetically modified apoM expression showed that apoM affects plasma HDL metabolism and development of atherosclerosis (10Christoffersen C. Jauhiainen M. Moser M. Porse B. Ehnholm C. Boesl M. Dahlback B. Nielsen L.B. J. Biol. Chem. 2007; 283: 1839-1847Abstract Full Text Full Text PDF PubMed Scopus (151) Google Scholar, 13Wolfrum C. Poy M.N. Stoffel M. Nat. Med. 2005; 11: 418-422Crossref PubMed Scopus (265) Google Scholar), but apoM also has antioxidant effects, and its physiological roles remain to be determined (10Christoffersen C. Jauhiainen M. Moser M. Porse B. Ehnholm C. Boesl M. Dahlback B. Nielsen L.B. J. Biol. Chem. 2007; 283: 1839-1847Abstract Full Text Full Text PDF PubMed Scopus (151) Google Scholar). Analysis of the tertiary structure of apoM by in silico homology modeling has revealed that apoM belongs to the lipocalin protein superfamily (14Duan J. Dahlback B. Villoutreix B.O. FEBS Lett. 2001; 499: 127-132Crossref PubMed Scopus (84) Google Scholar). Like in other lipocalins, the structure of apoM contains eight antiparallel β-sheets forming a small lipid-binding pocket. Recent experimental data confirmed the lipocalin structure of apoM and showed that it can bind retinoic acid and retinol (15Ahnstrom J. Faber K. Axler O. Dahlback B. J. Lipid Res. 2007; 48: 1754-1762Abstract Full Text Full Text PDF PubMed Scopus (63) Google Scholar). Human apoM can be glycosylated at amino acid Asn-135 surrounded by the glycosylation signal (12Xu N. Dahlback B. J. Biol. Chem. 1999; 274: 31286-31290Abstract Full Text Full Text PDF PubMed Scopus (270) Google Scholar). of with human plasma glycosylated apoM and a apoM of and (9Christoffersen C. Nielsen L.B. Axler O. Andersson A. Johnsen A.H. Dahlback B. J. Lipid Res. 2006; 47: 1833-1843Abstract Full Text Full Text PDF PubMed Scopus (151) Google Scholar, N. Dahlback B. J. Biol. Chem. 1999; 274: 31286-31290Abstract Full Text Full Text PDF PubMed Scopus (270) Google Scholar). The structure of apoM lacks external amphipathic motifs that the lipoprotein association of of plasma apoM has that it is secreted to the with its NH2-terminal signal peptide (12Xu N. Dahlback B. J. Biol. Chem. 1999; 274: 31286-31290Abstract Full Text Full Text PDF PubMed Scopus (270) Google Scholar). is cleavage of the NH2-terminal signal peptide by signal in the is as a for cellular of proteins to plasma. however, of at other plasma proteins with preserved NH2-terminal signal M. C. S. Biol. 1999; PubMed Scopus Google Scholar) and haptoglobin-related protein J. R. J. S. 1999; PubMed Google Scholar). Like apoM, and are mainly found in a of HDL not the HDL as that with apoM (9Christoffersen C. Nielsen L.B. Axler O. Andersson A. Johnsen A.H. Dahlback B. J. Lipid Res. 2006; 47: 1833-1843Abstract Full Text Full Text PDF PubMed Scopus (151) Google and in studies suggest that the signal peptide in can its association with lipoproteins M. C. S. Biol. 1999; PubMed Scopus Google Scholar). on and the hydrophobic of the signal we that the signal peptide serves as an anchor for apoM in plasma lipoprotein To test this and the of the signal peptide on the metabolism of plasma apoM, we generated mice that a mutated human apoMQ22A cDNA in the The cDNA a mutated human apoMQ22A protein glutamine in 22 is by The substitution results in secretion of apoM without its hydrophobic signal peptide (15Ahnstrom J. Faber K. Axler O. Dahlback B. J. Lipid Res. 2007; 48: 1754-1762Abstract Full Text Full Text PDF PubMed Scopus (63) Google Scholar). The mice expressing apoMQ22A were compared with mice expressing wild-type human and apoMQ22A-Tg mice expressing a human apoM protein without the signal peptide were in substitution of amino acid with in human apoM was (15Ahnstrom J. Faber K. Axler O. Dahlback B. J. Lipid Res. 2007; 48: 1754-1762Abstract Full Text Full Text PDF PubMed Scopus (63) Google Scholar). of apoMQ22A cDNA from was as (15Ahnstrom J. Faber K. Axler O. Dahlback B. J. Lipid Res. 2007; 48: 1754-1762Abstract Full Text Full Text PDF PubMed Scopus (63) Google Scholar) by (9Christoffersen C. Nielsen L.B. Axler O. Andersson A. Johnsen A.H. Dahlback B. J. Lipid Res. 2006; 47: 1833-1843Abstract Full Text Full Text PDF PubMed Scopus (151) Google Scholar) and O. J. Dahlback B. J. Lipid Res. 2007; 48: Full Text Full Text PDF PubMed Scopus Google Scholar). of the cDNA was with and and and into a The cDNA was into a from between a and an The of apoMQ22A cDNA was by be by The was from the by with and and the and used for into at the of Human apoMQ22A were by of a of human from with and (10Christoffersen C. Jauhiainen M. Moser M. Porse B. Ehnholm C. Boesl M. Dahlback B. Nielsen L.B. J. Biol. Chem. 2007; 283: 1839-1847Abstract Full Text Full Text PDF PubMed Scopus (151) Google Scholar). The human mice expressing wild-type human apoM were mice (10Christoffersen C. Jauhiainen M. Moser M. Porse B. Ehnholm C. Boesl M. Dahlback B. Nielsen L.B. J. Biol. Chem. 2007; 283: 1839-1847Abstract Full Text Full Text PDF PubMed Scopus (151) Google Both apoM-Tg and apoMQ22A-Tg mice were with mice for at the The mice were at the of and were from the in the into or and on Plasma was by at for at and at or were by the of mRNA was from tissue with and on an cDNA and with a was as M. Nielsen L.B. 2002; PubMed Scopus Google Scholar) with for human (10Christoffersen C. Jauhiainen M. Moser M. Porse B. Ehnholm C. Boesl M. Dahlback B. Nielsen L.B. J. Biol. Chem. 2007; 283: 1839-1847Abstract Full Text Full Text PDF PubMed Scopus (151) Google Scholar), K. Axler O. Dahlback B. Nielsen L.B. J. Lipid Res. Full Text Full Text PDF PubMed Scopus Google Scholar), and M. Nielsen L.B. 2002; PubMed Scopus Google Scholar). of Human wild-type apoM and recombinant human were measured with a against human apoM O. J. Dahlback B. J. Lipid Res. 2007; 48: Full Text Full Text PDF PubMed Scopus Google Scholar). The against human apoM used for (9Christoffersen C. Nielsen L.B. Axler O. Andersson A. Johnsen A.H. Dahlback B. J. Lipid Res. 2006; 47: 1833-1843Abstract Full Text Full Text PDF PubMed Scopus (151) Google Scholar) were apoM a apoM O. J. Dahlback B. J. Lipid Res. 2007; 48: Full Text Full Text PDF PubMed Scopus Google or a apoM apoM was with a apoM (10Christoffersen C. Jauhiainen M. Moser M. Porse B. Ehnholm C. Boesl M. Dahlback B. Nielsen L.B. J. Biol. Chem. 2007; 283: 1839-1847Abstract Full Text Full Text PDF PubMed Scopus (151) Google Scholar). Cell hepatocytes were from and wild-type mice Jr., S. J. Lipid Res. 2005; Full Text Full Text PDF PubMed Scopus Google Scholar). mice were with of liver by of The liver was in a with of at for in the tissue was with a a and with between was at for The were in of modified with and and on The of human apoM in was measured Lipoproteins were from in plasma or by of to with and in a at for and Plasma and of Human the plasma of apoM without the signal recombinant or wild-type human apoM were injected into wild-type mice, and the plasma was by human apoM plasma with human was produced as O. J. Dahlback B. J. Lipid Res. 2007; 48: Full Text Full Text PDF PubMed Scopus Google Scholar), and protein was measured with the protein and as a (9Christoffersen C. Nielsen L.B. Axler O. Andersson A. Johnsen A.H. Dahlback B. J. Lipid Res. 2006; 47: 1833-1843Abstract Full Text Full Text PDF PubMed Scopus (151) Google Scholar). For in of was with of plasma from a wild-type and injected into a wild-type mice of with of plasma from human apoM-Tg mice that human apoM (10Christoffersen C. Jauhiainen M. Moser M. Porse B. Ehnholm C. Boesl M. Dahlback B. Nielsen L.B. J. Biol. Chem. 2007; 283: 1839-1847Abstract Full Text Full Text PDF PubMed Scopus (151) Google Scholar). were and for of human To the lipoprotein association of human apoM, lipoproteins were from proteins in plasma as and the human apoM was determined in the by To tissue and we or with and injected it into wild-type mice. The is upon of the in studies of sites of plasma proteins Green Jr., Biochem. J. PubMed Scopus Google Scholar). tyramine was with in with of K. Nielsen L.B. K. S. 1996; PubMed Scopus Google Scholar). the was and to of or at To the and from and the was a The was for and for and and of the in the were with acid for and The of the proteins was by and of the was with a The of proteins was determined by the and or was injected into a of wild-type mice in a of were and the mice were and with Plasma and from and were in of and in a for To examine the cellular of were from by in of The tissue was in and in The were for for and in The were in a with a were by a and of of Plasma kidney of plasma proteins, apoMQ22A-Tg and wild-type mice were and the kidney was as S. F. K. Nielsen L.B. J. 15: PubMed Scopus Google Scholar) to ligation of the kidney The and were and the were of for for were and and the kidney of in examine the of the signal peptide on the metabolism of apoM, we used a mutated human apoMQ22A cDNA by to mice. The substitution a signal cleavage and results in secretion of a apoM without the signal peptide from were generated by of the into with an of the was for studies and compared with mice expressing wild-type human apoM (10Christoffersen C. Jauhiainen M. Moser M. Porse B. Ehnholm C. Boesl M. Dahlback B. Nielsen L.B. J. Biol. Chem. 2007; 283: 1839-1847Abstract Full Text Full Text PDF PubMed Scopus (151) Google Scholar). The apoMQ22A-Tg mice and were from wild-type mice. The liver expression of human apoM mRNA in the apoMQ22A-Tg mice was of that in apoM-Tg mice However, on of plasma with a human apoM was detectable in the apoM-Tg and not in apoMQ22A-Tg mice the apoM recombinant as well as wild-type human apoM that the of apoM in apoMQ22A-Tg plasma not the of of the In with the human apoM not be in the plasma from apoMQ22A-Tg mice with a human the plasma was as as The to human apoM and well with wild-type human apoM and recombinant apoM without the signal peptide The is the of human apoM in apoMQ22A-Tg mice is In the of human apoM is in the human apoM-Tg mice. The of detectable apoMQ22A in plasma was also in of eight apoMQ22A-Tg and was not on the of in the of human apoM effect on the plasma of apoM apoMQ22A is secreted from we that the of apoMQ22A in the apoMQ22A-Tg plasma most did not secretion from the To test this hepatocytes from and wild-type mice were in tissue Analysis of the by and showed that human apoM was secreted into the from apoMQ22A-Tg and apoM-Tg The of apoMQ22A in the was of that of wild-type human the of secretion of apoMQ22A and wild-type human apoM from the hepatocytes was similar to the amount of apoMQ22A and wild-type human apoM mRNA expression in the The of apoMQ22A in plasma secretion from the liver that the of the signal peptide rapid of apoMQ22A from plasma apoMQ22A associate with plasma lipoproteins. of the on Plasma of the of the signal peptide on the plasma metabolism of apoM, we produced a recombinant human without the signal peptide to amino of wild-type human in Escherichia coli and injected it into wild-type mice. showed that was rapidly cleared from plasma with of the injected in plasma the also the plasma metabolism of wild-type human apoM by plasma from apoM-Tg mice into wild-type the of wild-type human apoM was that of with and of the injected wild-type human apoM in plasma and To the lipoprotein association of lipoproteins were from the plasma proteins by at plasma of or wild-type human apoM was in the protein whereas wild-type human apoM was in the lipoprotein to the small and the of lipoprotein association of we that it be rapidly by filtration in the kidney. however, not any human apoM in the of apoMQ22A-Tg mice by or that if the kidney was a for removal of apoM without the signal the apoM be in the rather into the Indeed, we showed that the receptor which is on the of the can bind and apoM K. Dahlback B. Nielsen L.B. 2006; PubMed Scopus Google Scholar). To the tissue sites for and of we with and injected it into wild-type mice. studies were with human did not affect the of or as proteins as with the in to was rapidly from plasma the of the was in the whereas was in the plasma, and kidney To examine which of the were to The of in the kidney was in whereas a were in or The rapid plasma and by kidney of human were recombinant apoM without its signal peptide not The studies recombinant that the of human apoM in the plasma of apoMQ22A-Tg mice rapid removal of apoMQ22A in the kidney and that human apoM in the plasma of the apoMQ22A-Tg mice if kidney were To test this we kidney of plasma proteins by ligation of the arteries in and wild-type mice and measured human apoM in plasma with Indeed, human apoM detectable in plasma of the apoMQ22A-Tg mice kidney which the that apoM can be secreted from the liver without its signal peptide but that the of signal peptide results in rapid of the plasma protein by the kidney. The of human apoM in apoM-Tg mice did not ligation of the kidney arteries The NH2-terminal signal peptide roles in the of can protein (e.g. R.L. J.H. Proc. Natl. Acad. Sci. U. S. A. 2005; PubMed Scopus Google and proteins into (e.g. M. J. Biol. Chem. Full Text Full Text PDF PubMed Scopus Google or cellular (e.g. of the is to the E. A. E. 2006; PubMed Scopus Google Also, the hydrophobic of the signal peptide can anchor proteins in the of cleavage of the signal peptide of proteins that are secreted can in Wolf J. 2003; PubMed Scopus Google Scholar). In the however, human wild-type apoM and human apoMQ22A to be secreted from The results suggest that the signal peptide is for lipoprotein association and is to rapid of apoM from plasma. The in are in with a recent in by Axler O. J. Dahlback B. FEBS Lett. PubMed Scopus Google Scholar), that apoMQ22A to associate with HDL in the in ApoM its of the NH2-terminal signal peptide with and M. C. S. Biol. 1999; PubMed Scopus Google Scholar, J. R. J. S. 1999; PubMed Google Scholar). In plasma, proteins are mainly in the HDL The HDL is not in and (9Christoffersen C. Nielsen L.B. Axler O. Andersson A. Johnsen A.H. Dahlback B. J. Lipid Res. 2006; 47: 1833-1843Abstract Full Text Full Text PDF PubMed Scopus (151) Google Scholar), and is mainly of an HDL the which also contains apoA-I and apoL J. R. J. S. 1999; PubMed Google Scholar, B. Nielsen P. L. K. Pays E. Proc. Natl. Acad. Sci. U. S. A. 2007; PubMed Scopus Google Scholar). the signal not anchor the proteins to the HDL J. Proc. Natl. Acad. Sci. U. S. A. PubMed Scopus Google Scholar) and J. Biol. Chem. Full Text PDF PubMed Google Scholar) are also secreted without cleavage of their signal However, in the signal peptide are not at the of the proteins, and the hydrophobic are in the of the proteins P. P. Andersson H. T. J. Biol. Chem. Full Text PDF PubMed Google Scholar). is In silico the that the of the signal in apoM and results from the of a signal peptide cleavage for proteins, amino acid can in removal of the signal peptide to secretion (15Ahnstrom J. Faber K. Axler O. Dahlback B. J. Lipid Res. 2007; 48: 1754-1762Abstract Full Text Full Text PDF PubMed Scopus (63) Google Scholar, M. C. S. Biol. 1999; PubMed Scopus Google Scholar). In the case of HRP, however, the that the signal peptide can be and in expression in of an cDNA showed that the of is secreted from the without the signal peptide C. C. D. 2006; PubMed Scopus Google Scholar). Nevertheless, plasma the signal peptide. The data a for the even if a of is secreted with the signal peptide sequences, the of with the signal peptide in HDL from plasma, whereas without the signal peptide be rapidly from plasma. The physiological role of apoM to be or of apoM in mice affects plasma lipid metabolism (10Christoffersen C. Jauhiainen M. Moser M. Porse B. Ehnholm C. Boesl M. Dahlback B. Nielsen L.B. J. Biol. Chem. 2007; 283: 1839-1847Abstract Full Text Full Text PDF PubMed Scopus (151) Google Scholar, 13Wolfrum C. Poy M.N. Stoffel M. Nat. Med. 2005; 11: 418-422Crossref PubMed Scopus (265) Google Scholar), and in the plasma apoM is associated with O. J. Dahlback B. J. Lipid Res. 2007; 48: Full Text Full Text PDF PubMed Scopus Google Scholar). Nevertheless, apoM have roles beyond lipid HDL proteins with roles in inflammation and and HDL has in (1Vaisar T. Pennathur S. Green P.S. Gharib S.A. Hoofnagle A.N. Cheung M.C. Byun J. Vuletic S. Kassim S. Singh P. Chea H. Knopp R.H. Brunzell J. Geary R. Chait A. Zhao X.Q. Elkon K. Marcovina S. Ridker P. Oram J.F. Heinecke J.W. J. Clin. Investig. 2007; 117: 746-756Crossref PubMed Scopus (786) Google Scholar, S. M. A.M. Res. PubMed Scopus Google Scholar). it is that apoM, in of the plasma HDL particles (9Christoffersen C. Nielsen L.B. Axler O. Andersson A. Johnsen A.H. Dahlback B. J. Lipid Res. 2006; 47: 1833-1843Abstract Full Text Full Text PDF PubMed Scopus (151) Google Scholar), also have to lipid metabolism. For instance, apoM against lipid (9Christoffersen C. Nielsen L.B. Axler O. Andersson A. Johnsen A.H. Dahlback B. J. Lipid Res. 2006; 47: 1833-1843Abstract Full Text Full Text PDF PubMed Scopus (151) Google Scholar, C. Jauhiainen M. Moser M. Porse B. Ehnholm C. Boesl M. Dahlback B. Nielsen L.B. J. Biol. Chem. 2007; 283: 1839-1847Abstract Full Text Full Text PDF PubMed Scopus (151) Google Scholar) and retinol and retinoic acid in (15Ahnstrom J. Faber K. Axler O. Dahlback B. J. Lipid Res. 2007; 48: 1754-1762Abstract Full Text Full Text PDF PubMed Scopus (63) Google Scholar). The is by the lipocalin structure of apoM a small hydrophobic binding binding of small (14Duan J. Dahlback B. Villoutreix B.O. FEBS Lett. 2001; 499: 127-132Crossref PubMed Scopus (84) Google Scholar). is to that apoM is also found in a class in as of the for K. P. S. S. S. 2006; PubMed Scopus Google Scholar), that apoM have essential The data that the signal peptide in apoM serves an by the apolipoprotein to the of apoM in the kidney and apoM in plasma. and for
32
A molecular theory of lipid—protein interactions in the plasma lipoproteins
Jere P. Segrest, Richard L. Jackson, Joel D. Morrisett et al. · FEBS Letters · 1974 · 724 citations · Full text
Structure of apolipoprotein B-100 in low density lipoproteins
Jere P. Segrest, Martin K. Jones, Hans De Loof et al. · Journal of Lipid Research · 2001 · 514 citations · Full text
Apolipoprotein L-I is the trypanosome lytic factor of human serum
Luc Vanhamme, Françoise Paturiaux-Hanocq, Philippe Poelvoorde et al. · Nature · 2003 · 495 citations
A Novel Human Apolipoprotein (apoM)
Ning Xu, Björn Dahlbäck · Journal of Biological Chemistry · 1999 · 336 citations · Full text